Synachten is one of 2 small molecule programs targeting Cortisol. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
1 competitor in Cortisol
Adrenocorticotrophic Hormone
Synachten
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details